Saturday 17 October 2026 Export WORX’s income statement to Excel — free account

SCWorx Corp.

WORX Healthcare Health Information Services

SCWorx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 3.75% from fiscal 2024. In the quarter to June 2026, revenue grew 3.43%, EPS grew 98.4% and free cash flow grew 88.0%, each against the same quarter a year earlier.

1.40 0.61 −30.35%

Follow WORX

Alert me

Market cap: $1.1M
P/E: 0.1×
Fwd P/E: −2.6×
Dividend yield: —
F-score: 4/9
Altman Z: −5.04
Beneish M: −4.31
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 1.11

Revenue 2.93

Net Income (2.36)

Free Cash Flow (0.90)

Net Debt (1.26)

Current Ratio 2.19

Debt/Equity 0.00

P/E ratio 0.10

Fwd P/E (2.57)

P/S ratio 0.04

P/B ratio 0.02

Past 5Y EPS Growth —

This Y EPS Growth 21.60%

Next Y EPS Growth —

Next Y revenue growth (12.79%)

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 0.05%

10-year low 10-year high

P/B against its own 10 years 0.04%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2020	Powerpack
2019	Powerpack
2018	Powerpack
2017	Powerpack
2016	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	0	0	2	1
Receivables	0	0	0	0
Inventory	—	—	—	—
Other	—	—	—	—
	0	1	2	2

	2023	2024	2025	Q'26
Payables	2	1	1	1
ST’ Debt	—	—	—	—
Other	0	0	—	—
	2	2	1	1

Compound Annual Growth %

	10y	5y	3y
Sales	—	(11.21%)	(10.68%)
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	0.00%	4.52%	1.82%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	1	1	—	—	—
’25	1	1	1	1	3
’24	1	1	1	1	3
’23	1	1	1	1	4
’22	1	1	1	1	4
’21	1	1	1	1	5
’20	1	1	1	1	5

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Jun	Sep	Dec	Year
’26	0	—	—	—
’25	(1)	0	0	(2)
’24	0	(1)	0	(1)
’23	0	0	0	(1)
’22	0	0	0	(1)
’21	0	0	0	(1)
’20	(1)	0	0	(1)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Jun	Sep	Dec	Year
’26	0	—	—	—
’25	(1)	0	0	(2)
’24	0	(1)	0	(1)
’23	0	0	0	(1)
’22	0	0	0	(1)
’21	0	0	0	(1)
’20	(1)	0	0	(1)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(1.92)	(1.35)	—	—	—
’25	(45.00)	(82.79)	(27.00)	44.67	(109.79)
’24	(25.20)	(46.79)	(48.59)	(18.46)	(140.39)
’23	(80.95)	(26.98)	(137.12)	(443.53)	(694.73)
’22	(161.90)	(134.92)	(5.96)	(53.97)	(404.76)
’21	(188.89)	(323.81)	(242.85)	(202.71)	(979.53)
’20	(404.76)	(1.11k)	(770.83)	90.92	(2.21k)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	167,238.00	43,605.00	6,771.60	5,130.00	2,700.00	3,132.00	1,026.00	293.40	135.72	33.30	Analyst estimates 2026–2028 Powerpack
	High	280,611.00	204,840.91	79,002.00	30,753.00	40,176.00	13,500.00	3,996.00	2,592.00	799.20	367.20
People
People	Employees	36	34	4	4	9	10	9	7	7	9
	Revenue/emp, $m	0.02	0.01	0.86	1.39	0.58	0.46	0.45	0.54	0.43	0.32
Income, $m
Income, $m	Revenue	1	0	3	6	5	5	4	4	3	3
	Gross margin, %	35.00	100.00	14.83	21.02	32.57	39.94	35.01	33.35	24.95	31.96
	EBT	(5)	(3)	0	(11)	(7)	(4)	(2)	(4)	(1)	(4)
	EBT margin, %	(831.08)	(1,436.84)	(11.12)	(203.90)	(142.00)	(82.34)	(45.75)	(104.63)	(38.01)	(154.44)
	Net income	(4)	(12)	0	(11)	(7)	(4)	(2)	(4)	(1)	(4)
	Depreciation	0	0	0	0	0	0	—	—	0	3
Per share, $
Per share, $	Revenue	5,914.00	1,103.50	2,012.88	2,412.22	1,533.26	1,187.82	917.77	667.53	369.09	71.23
	Earnings	(38,649.65)	(57,448.54)	(229.45)	(4,884.07)	(2,222.87)	(984.02)	(404.76)	(694.73)	(140.39)	(109.79)
	Cash flow	(20,181.00)	(29,141.50)	(141.82)	(2,039.70)	(282.09)	(274.33)	(122.73)	(141.44)	(133.86)	(38.21)
	Capex	(1,116.00)	0.00	0.00	(48.57)	0.00	0.00	0.00	0.00	0.00	(0.76)
	Free cash flow	(21,297.00)	(29,141.50)	(141.82)	(2,088.26)	(282.09)	(274.33)	(122.73)	(141.44)	(133.86)	(38.97)
	Book value	137,118.00	40,672.50	(136.41)	3,011.13	1,686.47	1,642.33	1,540.11	676.04	554.27	177.04
	Shares, m	0	0	0	0	0	0	0	0	0	0
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	0.00	58.11	4.13	3.21	2.38	2.93	1.14	0.49	0.82	0.47
	P/B	1.40	1.58	0.00	2.57	2.16	2.12	0.68	0.49	0.55	0.19
	EV/Sales	0.00	58.45	4.17	3.17	2.41	3.07	1.19	0.56	0.89	(0.01)
	EV/FCF	(7.21)	(2.21)	(59.12)	(3.67)	(12.05)	(12.31)	(7.67)	(2.41)	(2.26)	0.02
Cash, $m
Cash, $m	Operating cash flow	(2)	(6)	0	(5)	(1)	(1)	(1)	(1)	(1)	(2)
	Capex	0	—	—	0	—	—	—	—	—	0
	Free cash flow	(2)	(6)	0	(5)	(1)	(1)	(1)	(1)	(1)	(2)
Balance, $m
Balance, $m	Working capital	5	(1)	0	(2)	(2)	(2)	(1)	(2)	(1)	1
	Total debt	—	0	2	—	0	0	0	0	0	—
	Net debt	(5)	0	1	0	0	0	0	0	0	(2)
	Shareholders’ equity	14	8	0	7	6	6	7	4	4	7
Returns, %
Returns, %	ROA	(59.33)	(100.87)	(5.95)	(173.71)	(71.80)	(38.63)	(20.11)	(51.29)	(18.00)	(62.41)
	ROIC	(33.98)	(24.49)	(7.77)	(115.51)	(66.85)	(35.23)	(19.88)	(23.54)	(17.88)	(10.88)
	ROE	(62.40)	(109.66)	(9.63)	(338.03)	(116.95)	(62.85)	(28.03)	(74.90)	(27.24)	(76.35)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
HLTHQ Cue Health Inc.	$6.9M	— (loss-making)	— (loss-making)	−87.19% (below 0%: shrinking)	n/m	+50.55% (above 0%: growing)	(90.14%)	(792.13%)	Compare
ZCMD Zhongchao Inc.	$6.2M	— (loss-making)	—	+20.44% (above 0%: growing)	−550.00% (below 0%: shrinking)	+191.85% (above 0%: growing)	41.67%	0.00%	Compare
ACON Aclarion, Inc.	$5.6M	— (loss-making)	— (loss-making)	+30.57% (above 0%: growing)	n/m	−41.41% (below 0%: shrinking)	32.94%	(11,506.75%)	Compare
VSEED VSee Health, Inc.	$2.8M	— (loss-making)	— (loss-making)	+48.02% (above 0%: growing)	n/m	−257.62% (below 0%: shrinking)	13.20%	(172.69%)	Compare
LGMK LogicMark, Inc.	$1.7M	— (loss-making)	— (loss-making)	+17.39% (above 0%: growing)	n/m	+96.41% (above 0%: growing)	70.71%	(47.60%)	Compare
MSPR MSP Recovery, Inc.	$1.5M	— (loss-making)	—	−94.60% (below 0%: shrinking)	n/m	+60.88% (above 0%: growing)	(26.77%)	(62,501.52%)	Compare
MNDR Mobile-health Network Solutions	$1.3M	—	—	—	—	—	—	—	Compare
WORX SCWorx Corp.	$1.1M	0.1×	— (loss-making)	+3.43% (above 0%: growing)	n/m	+87.99% (above 0%: growing)	46.80%	(17.14%)
ICCT iCoreConnect Inc.	$800.0K	— (loss-making)	—	−12.37% (below 0%: shrinking)	n/m	+91.63% (above 0%: growing)	74.39%	(129.31%)	Compare
Median of peers	$2.3M	—	—	+17.39%	—	+60.88%	32.94%	(172.69%)

All 51 Health Information Services stocks →

SCWorx Corp. (WORX) key facts

Concern: SCWorx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 3.75% from fiscal 2024.
SCWorx Corp. (WORX) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, WORX traded at $1.40, a market capitalization of $1.1 million.
Return on equity was −76.4% and debt-to-equity 0.00.
Its Piotroski F-score is 4 out of 9 and its Altman Z-score is −5.04 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.